EP3634948 - INHIBITORS OF RAC1 AND USES THEREOF FOR INDUCING BRONCHODILATATION [Right-click to bookmark this link] | Status | Examination is in progress Status updated on 04.06.2021 Database last updated on 16.11.2024 | |
Former | Request for examination was made Status updated on 26.02.2021 | ||
Former | Examination is in progress Status updated on 04.12.2020 | ||
Former | Request for examination was made Status updated on 13.03.2020 | ||
Former | The international publication has been made Status updated on 15.12.2018 | ||
Former | unknown Status updated on 15.06.2018 | Most recent event Tooltip | 07.08.2024 | New entry: Reply to examination report | Applicant(s) | For all designated states Institut National de la Santé et de la Recherche Médicale (INSERM) 101, rue de Tolbiac 75013 Paris / FR | For all designated states Centre National de la Recherche Scientifique 3, rue Michel-Ange 75016 Paris / FR | For all designated states Nantes Université 1 Quai de Tourville 44000 Nantes / FR | For all designated states Chu, Nantes Direction Generale 5 allée de l'île Gloriette 44000 Nantes / FR | [2023/18] |
Former [2020/16] | For all designated states Institut National de la Santé et de la Recherche Médicale (INSERM) 101, rue de Tolbiac 75013 Paris / FR | ||
For all designated states Centre National de la Recherche Scientifique 3, rue Michel-Ange 75016 Paris / FR | |||
For all designated states Universite de Nantes 1 quai de Tourville 44000 Nantes / FR | |||
For all designated states Chu, Nantes Direction Generale 5 allée de l'île Gloriette 44000 Nantes / FR | Inventor(s) | 01 /
SAUZEAU, Vincent 32 rue de Beau Soleil 44340 Bouguenais / FR | 02 /
LOIRAND, Gervaise 6 rue Duguay-Trouin 44470 Thouaré-sur-Loire / FR | 03 /
LEBRETON, Jacques 1 bis rue des fleurs 44300 Nantes / FR | 04 /
TESSIER, Arnaud 9 rue des ajoncs d'or 44700 Orvault / FR | 05 /
QUEMENIER, Agnès 31 rue Marange Sylvange 44100 Nantes / FR | [2020/16] | Representative(s) | Lavoix 2, place d'Estienne d'Orves 75441 Paris Cedex 09 / FR | [2020/16] | Application number, filing date | 18728642.2 | 06.06.2018 | [2020/16] | WO2018EP64920 | Priority number, date | EP20170305662 | 06.06.2017 Original published format: EP 17305662 | [2020/16] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2018224560 | Date: | 13.12.2018 | Language: | EN | [2018/50] | Type: | A1 Application with search report | No.: | EP3634948 | Date: | 15.04.2020 | Language: | EN | The application published by WIPO in one of the EPO official languages on 13.12.2018 takes the place of the publication of the European patent application. | [2020/16] | Search report(s) | International search report - published on: | EP | 13.12.2018 | (Supplementary) European search report - dispatched on: | EP | 04.06.2021 | Classification | IPC: | C07C311/21, C07C311/44, A61K31/63, A61P11/06 | [2020/16] | CPC: |
C07C311/44 (EP);
A61K31/63 (US);
A61P11/06 (EP,US);
C07C311/21 (EP);
C07C323/62 (EP)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2020/16] | Title | German: | INHIBITOREN VON RAC1 UND VERWENDUNGEN DAVON ZUR AUSLÖSUNG VON BRONCHODILATATION | [2020/16] | English: | INHIBITORS OF RAC1 AND USES THEREOF FOR INDUCING BRONCHODILATATION | [2020/16] | French: | INHIBITEURS DE RAC1 ET LEURS UTILISATIONS POUR INDUIRE UNE BRONCHODILATATION | [2020/16] | Entry into regional phase | 03.12.2019 | National basic fee paid | 03.12.2019 | Designation fee(s) paid | 03.12.2019 | Examination fee paid | Examination procedure | 03.12.2019 | Examination requested [2020/16] | 03.12.2019 | Date on which the examining division has become responsible | 10.07.2020 | Amendment by applicant (claims and/or description) | 04.06.2021 | Despatch of a communication from the examining division to which search results under Rule 164(2) EPC are annexed (Time limit: M06) [2021/27] | 04.06.2021 | Despatch of a communication from the examining division (Time limit: M06) | 14.12.2021 | Reply to a communication from the examining division | 23.12.2022 | Despatch of a communication from the examining division (Time limit: M04) | 07.04.2023 | Reply to a communication from the examining division | 15.04.2024 | Despatch of a communication from the examining division (Time limit: M04) | 06.08.2024 | Reply to a communication from the examining division | Fees paid | Renewal fee | 22.05.2020 | Renewal fee patent year 03 | 28.05.2021 | Renewal fee patent year 04 | 25.05.2022 | Renewal fee patent year 05 | 25.05.2023 | Renewal fee patent year 06 | 27.05.2024 | Renewal fee patent year 07 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [X]US2192490 (KURT WARNAT); | [X]US2407309 (LOTT WILLIAM A, et al); | [X]US5932599 (BOES MICHAEL [CH], et al); | [Y]WO0198274 (CELLTECH CHIROSCIENCE LTD [GB], et al); | [X]US6521658 (LI QUN [US], et al); | [Y]WO2007003934 (STERIX LTD [GB], et al); | [X]CN101429142 (UNIV SHANDONG [CN]); | [X]WO2012142698 (UNIV LAVAL [CA], et al); | [XY]WO2013009799 (BETH ISRAEL HOSPITAL [US], et al); | Examination | WO2005013914 | WO2013009799 |